| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06749899 | QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in… | Nasopharyngeal Cancinoma (NPC) | Recruiting |
| NCT07058428 | FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma | Multiple Brain Metastases in Lung Adenocarcinoma | Recruiting |
| NCT04722978 | Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic… | Triple Negative Breast Cancer | Recruiting |
| Phase 2 | |||
| NCT06013618 | Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or… | Neuroblastoma | Recruiting |
| Phase 1/2 | |||
| NCT06836505 | Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and… | Neuroblastoma (NB) | Recruiting |
| NCT07288814 | Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients… | Relapsed or Refractory Peripheral T Cell Lymphoma | Not Yet Recruiting |
| Not specified | |||
| NCT06561178 | Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT04174079 | Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic… | Thoracic Esophageal Squamous Cell Carcinoma | Recruiting |